Holen Sie sich die Stockscreener-App
350.48
0.27%
-0.94
Handel nachbörslich:
350.81
0.33
+0.09%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ELV?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$351.42
Offen:
$345.12
24-Stunden-Volumen:
1.60M
Relative Volume:
0.68
Marktkapitalisierung:
$78.92B
Einnahmen:
$189.25B
Nettoeinkommen (Verlust:
$5.35B
KGV:
14.92
EPS:
23.4948
Netto-Cashflow:
$5.34B
1W Leistung:
-1.96%
1M Leistung:
+12.42%
6M Leistung:
-20.56%
1J Leistung:
-31.15%
1-Tages-Spanne:
$344.37
$351.43
1-Wochen-Bereich:
$344.37
$364.87
52-Wochen-Spanne:
$273.71
$497.34
Elevance Health Inc Stock (ELV) Company Profile
Firmenname
Elevance Health Inc
Sektor
Branche
Telefon
(800) 331-1476
Adresse
220 VIRGINIA AVENUE, INDIANAPOLIS
Vergleichen Sie ELV mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ELV
Elevance Health Inc
|
350.48 | 79.13B | 189.25B | 5.35B | 5.34B | 23.49 |
|
UNH
Unitedhealth Group Inc
|
359.93 | 324.83B | 422.82B | 22.09B | 25.27B | 23.09 |
|
CVS
Cvs Health Corp
|
79.66 | 99.49B | 386.46B | 4.49B | 4.78B | 3.5841 |
|
CI
Cigna Group
|
302.13 | 78.85B | 261.22B | 5.40B | 3.94B | 18.31 |
|
HUM
Humana Inc
|
261.61 | 32.59B | 123.11B | 1.58B | 2.44B | 13.03 |
Elevance Health Inc Stock (ELV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-21 | Herabstufung | Argus | Buy → Hold |
| 2025-07-18 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2025-04-15 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2025-03-17 | Hochstufung | Argus | Hold → Buy |
| 2025-01-22 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2024-10-18 | Herabstufung | Argus | Buy → Hold |
| 2024-07-18 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-06-24 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-03-06 | Eingeleitet | Barclays | Overweight |
| 2023-07-12 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2023-04-27 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-03-28 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-09-09 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-08-22 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
Alle ansehen
Elevance Health Inc Aktie (ELV) Neueste Nachrichten
NYSE: ELV Lawsuit Update: Investors in Elevance Health, Inc. (NYSE: ELV) shares should contact the Shareholders Foundation in connection with pending Lawsuit - PR Newswire
Analyzing recovery setups for Elevance Health Inc. investorsJuly 2025 Highlights & Consistent Growth Equity Picks - newser.com
Is Elevance Health Inc. stock supported by strong cash flows2025 Winners & Losers & Verified Swing Trading Watchlists - newser.com
Is Elevance Health Inc. stock trading at a premium valuationTrade Analysis Report & Daily Oversold Bounce Ideas - newser.com
Applying chart zones and confluence areas to Elevance Health Inc.Market Activity Recap & Precise Swing Trade Entry Alerts - newser.com
Chart based exit strategy for Elevance Health Inc.Portfolio Update Report & Free Risk Controlled Daily Trade Plans - newser.com
Key metrics from Elevance Health Inc.’s quarterly dataJuly 2025 Catalysts & Long-Term Capital Growth Strategies - newser.com
Trend analysis for Elevance Health Inc. this weekGlobal Markets & Reliable Intraday Trade Plans - newser.com
Elevance Health, Inc. $ELV Shares Bought by Verdence Capital Advisors LLC - MarketBeat
Vest Financial LLC Buys 14,809 Shares of Elevance Health, Inc. $ELV - MarketBeat
Pzena Investment Management LLC Acquires 16,296 Shares of Elevance Health, Inc. $ELV - MarketBeat
How Elevance Health Inc. stock reacts to Fed rate cutsBond Market & AI Powered Market Trend Analysis - newser.com
How to interpret RSI for Elevance Health Inc. stock2025 Price Momentum & Low Risk Entry Point Guides - newser.com
Real time breakdown of Elevance Health Inc. stock performanceQuarterly Investment Review & Reliable Volume Spike Alerts - newser.com
Lawson Kroeker Investment Management Inc. NE Raises Stock Holdings in Elevance Health, Inc. $ELV - MarketBeat
Vanguard Personalized Indexing Management LLC Raises Holdings in Elevance Health, Inc. $ELV - MarketBeat
Elevance Health, Inc. $ELV Shares Sold by Drucker Wealth 3.0 LLC - MarketBeat
Stonehage Fleming Financial Services Holdings Ltd Buys Shares of 2,292 Elevance Health, Inc. $ELV - MarketBeat
Lmcg Investments LLC Reduces Holdings in Elevance Health, Inc. $ELV - MarketBeat
Vontobel Holding Ltd. Sells 732 Shares of Elevance Health, Inc. $ELV - MarketBeat
Callan Family Office LLC Has $1.75 Million Stock Position in Elevance Health, Inc. $ELV - MarketBeat
Elevance Health (NYSE:ELV) Price Target Raised to $370.00 - MarketBeat
Triodos Investment Management BV Has $36.24 Million Position in Elevance Health, Inc. $ELV - MarketBeat
Elevance Health, Inc. $ELV Shares Sold by Aberdeen Group plc - MarketBeat
Ramirez Asset Management Inc. Increases Stock Holdings in Elevance Health, Inc. $ELV - MarketBeat
B of A Securities Maintains Elevance Health (ELV) Neutral Recommendation - Nasdaq
Market reaction to Elevance Health Inc.’s recent newsJuly 2025 Final Week & Low Drawdown Trading Strategies - newser.com
Group Health Insurance Market Is Booming Worldwide 2025-2032 | UnitedHealth Group, Anthem (Elevance Health) - InsuranceNewsNet
Elevance Health Q3 EPS Forecast Decreased by Wolfe Research - MarketBeat
When is the best time to exit Elevance Health Inc.2025 Historical Comparison & Growth Oriented Trade Recommendations - newser.com
Elevance Health Reaffirms 2025 Earnings Guidance - MSN
Elevance Health (ELV) Analyst Rating Update: Price Target Raised by Mizuho | ELV Stock News - GuruFocus
What’s next for Elevance Health Inc. stock priceBull Run & Weekly High Momentum Picks - newser.com
Will Elevance Health Inc. stock outperform global peersJuly 2025 Intraday Action & Long-Term Safe Investment Plans - newser.com
Elevance Health (NYSE:ELV) Upgraded by Weiss Ratings to Hold (C-) Rating - MarketBeat
Strategies to average down on Elevance Health Inc.Gap Down & Stock Timing and Entry Methods - newser.com
Barclays Maintains Elevance Health (ELV) Overweight Recommendation - Nasdaq
Can Digital Workflows at Optum Rx Transform UNH's Patient Experience? - The Globe and Mail
Bronstein, Gewirtz & Grossman, LLC Is Investigating Elevance Health, Inc. (ELV) And Encourages Shareholders to Connect - ACCESS Newswire
Mizuho Adjusts Price Target on Elevance Health to $420 From $342, Maintains Outperform Rating - MarketScreener
Elevance Health (ELV): Barclays Raises Price Target to $395 | ELV Stock News - GuruFocus
Is Elevance Health, Inc.'s (NYSE:ELV) Stock's Recent Performance Being Led By Its Attractive Financial Prospects? - 富途牛牛
Elevance Health Reaches Analyst Target Price - Nasdaq
Does Elevance Health (NYSE:ELV) Have A Healthy Balance Sheet? - Yahoo Finance
Analysts recommendations: Datadog, Alphabet, AMD, Elevance Health, Tesla… - MarketScreener
Backtesting results for Elevance Health Inc. trading strategiesMarket Risk Analysis & Safe Entry Zone Tips - newser.com
Elevance Health Shrinks to Grow Stronger: From Part D to Plan B? - MSN
Guggenheim Maintains Elevance Health (ELV) Buy Recommendation - Nasdaq
Elevance Health, Inc. (ELV) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Healthcare: Policy Headwinds Continue to Weigh on Stocks, but Valuations Remain Attractive - Morningstar
Guggenheim Adjusts Elevance Health Price Target to $398 From $360, Maintains Buy Rating - MarketScreener
Finanzdaten der Elevance Health Inc-Aktie (ELV)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.27%
3.46%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):